Skip to main content
Top
Published in: Inflammation 4/2016

01-08-2016 | ORIGINAL ARTICLE

Isorhamnetin ameliorates LPS-induced inflammatory response through downregulation of NF-κB signaling

Authors: Yang Li, Gefu Chi, Bingyu Shen, Ye Tian, Haihua Feng

Published in: Inflammation | Issue 4/2016

Login to get access

Abstract

Isorhamnetin, a flavonoid mainly found in Hippophae fhamnoides L. fruit, has been known for its antioxidant activity and its ability to regulate immune response. In this study, we investigated whether isorhamnetin exerts potent antiinflammatory effects in RAW264.7 cell and mouse model stimulated by LPS. The cytokine (TNF-α, IL-1β, and IL-6) levels were determined. In the mouse model of acute lung injury, the phosphorylation of NF-κB proteins was analyzed and inhibitor of NF-κB signaling (PDTC) was used on mice. Our results showed that isorhamnetin markedly decreased TNF-α, IL-1β, and IL-6 concentrations and suppressed the activation of NF-κB signaling. Meanwhile, isorhamnetin reduced the amount of inflammatory cells, the lung wet-to-dry weight ratio, protein leakage, and myeloperoxidase activity. Interference with specific inhibitor revealed that isorhamnetin-mediated suppression of cytokines and protein was via NF-κB signaling. So, it suggests that isorhamnetin might be a potential therapeutic agent for preventing inflammatory diseases.
Literature
1.
go back to reference Helmick, C.G., D.T. Felson, R.C. Lawrence, S. Gabriel, R. Hirsch, C.K. Kwoh, M.H. Liang, H.M. Kremers, M.D. Mayes, P.A. Merkel, S.R. Pillemer, J.D. Reveille, and J.H. Stone. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis and Rheumatism 58: 15–25.CrossRefPubMed Helmick, C.G., D.T. Felson, R.C. Lawrence, S. Gabriel, R. Hirsch, C.K. Kwoh, M.H. Liang, H.M. Kremers, M.D. Mayes, P.A. Merkel, S.R. Pillemer, J.D. Reveille, and J.H. Stone. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis and Rheumatism 58: 15–25.CrossRefPubMed
2.
go back to reference Lawrence, R.C., D.T. Felson, C.G. Helmick, L.M. Arnold, H. Choi, R.A. Deyo, S. Gabriel, R. Hirsch, M.C. Hochberg, G.G. Hunder, J.M. Jordan, J.N. Katz, H.M. Kremers, and F. Wolfe. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis and Rheumatism 58: 26–35.CrossRefPubMedPubMedCentral Lawrence, R.C., D.T. Felson, C.G. Helmick, L.M. Arnold, H. Choi, R.A. Deyo, S. Gabriel, R. Hirsch, M.C. Hochberg, G.G. Hunder, J.M. Jordan, J.N. Katz, H.M. Kremers, and F. Wolfe. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis and Rheumatism 58: 26–35.CrossRefPubMedPubMedCentral
3.
4.
go back to reference Brigham, K.L., and B. Meyrick. 1986. Endotoxin and lung injury. American Review of Respiratory Disease 133: 913–927.PubMed Brigham, K.L., and B. Meyrick. 1986. Endotoxin and lung injury. American Review of Respiratory Disease 133: 913–927.PubMed
5.
go back to reference Kim, T.H., H.J. Yoon, C.M. Lim, E.K. Kim, M.J. Kim, and Y. Koh. 2005. The role of endogenous histamine on the pathogenesis of the lipopoly-saccharide (LPS)-induced acute lung injury: a pilot study. Inflammation 29: 72–80.CrossRefPubMed Kim, T.H., H.J. Yoon, C.M. Lim, E.K. Kim, M.J. Kim, and Y. Koh. 2005. The role of endogenous histamine on the pathogenesis of the lipopoly-saccharide (LPS)-induced acute lung injury: a pilot study. Inflammation 29: 72–80.CrossRefPubMed
6.
go back to reference Matthay, M.A., and G.A. Zimmerman. 2005. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. American Journal of Respiratory Cell and Molecular Biology 33: 319–327.CrossRefPubMedPubMedCentral Matthay, M.A., and G.A. Zimmerman. 2005. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. American Journal of Respiratory Cell and Molecular Biology 33: 319–327.CrossRefPubMedPubMedCentral
7.
go back to reference Libby, P. 2000. Coronary artery injury and the biology of atherosclerosis: In ammation, thrombosis, and stabilization. American Journal of Cardiology 86: 3J–8J (discussion 8 J-9 J).CrossRefPubMed Libby, P. 2000. Coronary artery injury and the biology of atherosclerosis: In ammation, thrombosis, and stabilization. American Journal of Cardiology 86: 3J–8J (discussion 8 J-9 J).CrossRefPubMed
8.
go back to reference Bone, R.C. 1996. The sepsis syndrome. Definition and general approach to management. Clinics in Chest Medicine 17: 175–181.CrossRefPubMed Bone, R.C. 1996. The sepsis syndrome. Definition and general approach to management. Clinics in Chest Medicine 17: 175–181.CrossRefPubMed
10.
go back to reference Venaille, T.J., G. Ryan, and B.W. Robinson. 1998. Epithelial cell damage is induced by neutrophil-derived, not pseudomonas-derived, proteases in cystic fibrosis sputum. Respiratory Medicine 92: 233–240.CrossRefPubMed Venaille, T.J., G. Ryan, and B.W. Robinson. 1998. Epithelial cell damage is induced by neutrophil-derived, not pseudomonas-derived, proteases in cystic fibrosis sputum. Respiratory Medicine 92: 233–240.CrossRefPubMed
11.
go back to reference Kim, H.J., H.S. Lee, Y.H. Chong, and J.L. Kang. 2006. p38 mitogen-activated protein kinas up-regulates LPS-induced NF-κB activation in the development of lung injury and RAW 264.7 macrophages. Toxicology 225: 36–47.CrossRefPubMed Kim, H.J., H.S. Lee, Y.H. Chong, and J.L. Kang. 2006. p38 mitogen-activated protein kinas up-regulates LPS-induced NF-κB activation in the development of lung injury and RAW 264.7 macrophages. Toxicology 225: 36–47.CrossRefPubMed
13.
go back to reference Ghosh, S., M.J. May, and E.B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annual Review of Immunology 16: 225–260.CrossRefPubMed Ghosh, S., M.J. May, and E.B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annual Review of Immunology 16: 225–260.CrossRefPubMed
14.
go back to reference Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-kappa B in the immune system. Annual Review of Immunology 12: 141–179.CrossRefPubMed Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-kappa B in the immune system. Annual Review of Immunology 12: 141–179.CrossRefPubMed
15.
go back to reference Yang, R., L. Yang, X. Shen, W. Cheng, B. Zhao, K.H. Ali, Z. Qian, and H. Ji. 2012. Suppression of NF-κB pathway by crocetin contributes to attenuation of lipopolysaccharide-induced acute lung injury in mice. European Journal of Pharmacology 674: 391–396.CrossRefPubMed Yang, R., L. Yang, X. Shen, W. Cheng, B. Zhao, K.H. Ali, Z. Qian, and H. Ji. 2012. Suppression of NF-κB pathway by crocetin contributes to attenuation of lipopolysaccharide-induced acute lung injury in mice. European Journal of Pharmacology 674: 391–396.CrossRefPubMed
16.
go back to reference Lee, H.J., H.J. Lee, E.O. Lee, S.G. Ko, H.S. Bae, C.H. Kim, K.S. Ahh, J. Lu, and S.H. Kim. 2008. Mitochondria-cytochrome C-caspase-9 cascade mediates isorhamnetin-induced apoptosis. Cancer Letters 270: 342–353.CrossRefPubMed Lee, H.J., H.J. Lee, E.O. Lee, S.G. Ko, H.S. Bae, C.H. Kim, K.S. Ahh, J. Lu, and S.H. Kim. 2008. Mitochondria-cytochrome C-caspase-9 cascade mediates isorhamnetin-induced apoptosis. Cancer Letters 270: 342–353.CrossRefPubMed
17.
go back to reference Boesch-Saadatmandi, C., S. Egert, C. Schrader, X. Coumoul, R. Barouki, M.J. Muller, S. Wolffram, and G. Rimbach. 2010. Effect of quercetin on paraoxonase 1 activity-studies in cultured cells, mice and humans. Journal of Physiology and Pharmacology 61: 99–105.PubMed Boesch-Saadatmandi, C., S. Egert, C. Schrader, X. Coumoul, R. Barouki, M.J. Muller, S. Wolffram, and G. Rimbach. 2010. Effect of quercetin on paraoxonase 1 activity-studies in cultured cells, mice and humans. Journal of Physiology and Pharmacology 61: 99–105.PubMed
18.
go back to reference Jiang, J.S., C.M. Shih, S.H. Wang, T.T. Chen, C.N. Lin, and W.C. Ko. 2006. Mechanisms of suppression of nitric oxide production by 3-O-methylquercetin in RAW 264.7 cells. Journal of Ethnopharmacology 103: 281–287.CrossRefPubMed Jiang, J.S., C.M. Shih, S.H. Wang, T.T. Chen, C.N. Lin, and W.C. Ko. 2006. Mechanisms of suppression of nitric oxide production by 3-O-methylquercetin in RAW 264.7 cells. Journal of Ethnopharmacology 103: 281–287.CrossRefPubMed
19.
go back to reference Yang, J.H., S.C. Kim, B.Y. Shin, S.H. Jin, M.J. Jo, K.H. Jegal, Y.W. Kim, J.R. Lee, S.K. Ku, I.J. Cho, and S.H. Ki. 2013. O-methylated flavonol isorhamnetin prevents acute inflammation through blocking of NF-κB activation. Food and Chemical Toxicology 59: 362–372.CrossRefPubMed Yang, J.H., S.C. Kim, B.Y. Shin, S.H. Jin, M.J. Jo, K.H. Jegal, Y.W. Kim, J.R. Lee, S.K. Ku, I.J. Cho, and S.H. Ki. 2013. O-methylated flavonol isorhamnetin prevents acute inflammation through blocking of NF-κB activation. Food and Chemical Toxicology 59: 362–372.CrossRefPubMed
20.
go back to reference Saud, S.M., M.R. Young, Y.L. Jones-Hall, L. Ileva, M.O. Evbuomwan, J. Wise, N.H. Colburn, Y.S. Kim, and G. Bobe. 2013. Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and β-catenin. Cancer Research 73: 5473–5484.CrossRefPubMed Saud, S.M., M.R. Young, Y.L. Jones-Hall, L. Ileva, M.O. Evbuomwan, J. Wise, N.H. Colburn, Y.S. Kim, and G. Bobe. 2013. Chemopreventive activity of plant flavonoid isorhamnetin in colorectal cancer is mediated by oncogenic Src and β-catenin. Cancer Research 73: 5473–5484.CrossRefPubMed
21.
go back to reference Dou, W., J. Zhang, H. Li, S. Kortagere, K. Sun, L. Ding, G. Ren, Z. Wang, and S. Mani. 2014. Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway. Journal of Nutritional Biochemistry 25: 923–933.CrossRefPubMedPubMedCentral Dou, W., J. Zhang, H. Li, S. Kortagere, K. Sun, L. Ding, G. Ren, Z. Wang, and S. Mani. 2014. Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway. Journal of Nutritional Biochemistry 25: 923–933.CrossRefPubMedPubMedCentral
22.
go back to reference Wu, Y., M. Singer, F. Thouron, M. Alaoui-El-Azher, and L. Touqui. 2002. Effect of surfactant on pulmonary expression of type IIA PLA(2) in an animal model of acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 282: L743–L750.CrossRefPubMed Wu, Y., M. Singer, F. Thouron, M. Alaoui-El-Azher, and L. Touqui. 2002. Effect of surfactant on pulmonary expression of type IIA PLA(2) in an animal model of acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 282: L743–L750.CrossRefPubMed
23.
go back to reference Luo, Y., B. Zhang, D.Q. Xu, Y. Liu, M.Q. Dong, P.T. Zhao, and Z.C. Li. 2011. Protective effect of on lipopolysaccharide-induced acute lung injury in mice. Pulmonary Pharmacology & Therapeutics 24: 240–246.CrossRef Luo, Y., B. Zhang, D.Q. Xu, Y. Liu, M.Q. Dong, P.T. Zhao, and Z.C. Li. 2011. Protective effect of on lipopolysaccharide-induced acute lung injury in mice. Pulmonary Pharmacology & Therapeutics 24: 240–246.CrossRef
24.
go back to reference Yin, H., X.Y. Li, B.H. Yuan, B.B. Zhang, S.L. Hu, H.B. Gu, X.B. Jin, and J.Y. Zhu. 2011. Adenovirus-mediated overexpression of soluble ST2 provides a protective effect on lipopolysaccharide-induced acute lung injury in mice. Clinical and Experimental Immunology 164: 248–255.CrossRefPubMedPubMedCentral Yin, H., X.Y. Li, B.H. Yuan, B.B. Zhang, S.L. Hu, H.B. Gu, X.B. Jin, and J.Y. Zhu. 2011. Adenovirus-mediated overexpression of soluble ST2 provides a protective effect on lipopolysaccharide-induced acute lung injury in mice. Clinical and Experimental Immunology 164: 248–255.CrossRefPubMedPubMedCentral
25.
go back to reference Mecklenburgh, K., J. Murray, T. Brazil, C. Ward, A.G. Rossi, and E.R. Chilvers. 1999. Role of neutrophil apoptosis in the resolution of pulmonary in ammation. Monaldi Archives for Chest Disease 54: 345–349.PubMed Mecklenburgh, K., J. Murray, T. Brazil, C. Ward, A.G. Rossi, and E.R. Chilvers. 1999. Role of neutrophil apoptosis in the resolution of pulmonary in ammation. Monaldi Archives for Chest Disease 54: 345–349.PubMed
26.
27.
go back to reference Strieter, R.M., and S.L. Kunkel. 1994. Acute lung injury: the role of cytokines in the elicitation of neutrophils. Journal of Investigative Medicine 42: 640–651.PubMed Strieter, R.M., and S.L. Kunkel. 1994. Acute lung injury: the role of cytokines in the elicitation of neutrophils. Journal of Investigative Medicine 42: 640–651.PubMed
28.
go back to reference Kobayashi, A., S. Hashimoto, K. Kooguchi, Y. Kitamura, H. Onodera, Y. Urata, and T. Ashihara. 1998. Expression of inducible nitric oxide synthase and in ammatory cytokines in alveolar macrophages of ARDS following sepsis. Chest 113: 1632–1639.CrossRefPubMed Kobayashi, A., S. Hashimoto, K. Kooguchi, Y. Kitamura, H. Onodera, Y. Urata, and T. Ashihara. 1998. Expression of inducible nitric oxide synthase and in ammatory cytokines in alveolar macrophages of ARDS following sepsis. Chest 113: 1632–1639.CrossRefPubMed
29.
go back to reference Shinbori, T., H. Walczak, and P.H. Krammer. 2004. Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-in ammatory cytokine TNF-alpha. European Journal of Immunology 34: 1762–1770.CrossRefPubMed Shinbori, T., H. Walczak, and P.H. Krammer. 2004. Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-in ammatory cytokine TNF-alpha. European Journal of Immunology 34: 1762–1770.CrossRefPubMed
30.
go back to reference Giebelen, I.A., D.J. van Westerloo, G.J. LaRosa, A.F. de Vos, and T. van der Poll. 2007. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 28: 700–703.PubMed Giebelen, I.A., D.J. van Westerloo, G.J. LaRosa, A.F. de Vos, and T. van der Poll. 2007. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 28: 700–703.PubMed
31.
32.
go back to reference Kang, J.L., H.W. Lee, H.S. Lee, I.S. Pack, Y. Chong, V. Castranova, and Y. Koh. 2001. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. American Journal of Respiratory and Critical Care Medicine 164: 2206–2212.CrossRefPubMed Kang, J.L., H.W. Lee, H.S. Lee, I.S. Pack, Y. Chong, V. Castranova, and Y. Koh. 2001. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide. American Journal of Respiratory and Critical Care Medicine 164: 2206–2212.CrossRefPubMed
33.
go back to reference Liu, S., G. Feng, G.L. Wang, and G.J. Liu. 2008. p38MAPK inhibition attenu-ates LPS-induced acute lung injury involvement of NF-kappaB pathway. European Journal of Pharmacology 584: 159–165.CrossRefPubMed Liu, S., G. Feng, G.L. Wang, and G.J. Liu. 2008. p38MAPK inhibition attenu-ates LPS-induced acute lung injury involvement of NF-kappaB pathway. European Journal of Pharmacology 584: 159–165.CrossRefPubMed
34.
go back to reference Xia, Y.F., B.Q. Ye, Y.D. Li, J.G. Wang, X.J. He, X. Lin, X. Yao, D. Ma, A. Slungaard, R.P. Hebbel, N.S. Key, and J.G. Geng. 2004. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. Journal of Immunology 173: 4207–4217.CrossRef Xia, Y.F., B.Q. Ye, Y.D. Li, J.G. Wang, X.J. He, X. Lin, X. Yao, D. Ma, A. Slungaard, R.P. Hebbel, N.S. Key, and J.G. Geng. 2004. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. Journal of Immunology 173: 4207–4217.CrossRef
35.
go back to reference Li, Q., and I.M. Verma. 2002. NF-kappa B regulation in the immune system. Nature Reviews Immunology 2: 725–734.CrossRefPubMed Li, Q., and I.M. Verma. 2002. NF-kappa B regulation in the immune system. Nature Reviews Immunology 2: 725–734.CrossRefPubMed
36.
go back to reference Manca, D., A.C. Ricard, B. Trottier, and G. Chevalier. 1991. Studies on lipid peroxidation in rat tissues following administration of low and moderate doses of cadmium chloride. Toxicology 67: 303–323.CrossRefPubMed Manca, D., A.C. Ricard, B. Trottier, and G. Chevalier. 1991. Studies on lipid peroxidation in rat tissues following administration of low and moderate doses of cadmium chloride. Toxicology 67: 303–323.CrossRefPubMed
37.
go back to reference Zhang, G., and S. Ghosh. 2001. Toll-like receptor-mediated NF-kB activation: a phylogenetically conserved paradigm in innate immunity. Journal of Clinical Investigation 107: 13–19.CrossRefPubMedPubMedCentral Zhang, G., and S. Ghosh. 2001. Toll-like receptor-mediated NF-kB activation: a phylogenetically conserved paradigm in innate immunity. Journal of Clinical Investigation 107: 13–19.CrossRefPubMedPubMedCentral
Metadata
Title
Isorhamnetin ameliorates LPS-induced inflammatory response through downregulation of NF-κB signaling
Authors
Yang Li
Gefu Chi
Bingyu Shen
Ye Tian
Haihua Feng
Publication date
01-08-2016
Publisher
Springer US
Published in
Inflammation / Issue 4/2016
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0361-z

Other articles of this Issue 4/2016

Inflammation 4/2016 Go to the issue